A detailed history of Ameritas Advisory Services, LLC transactions in Novartis Ag stock. As of the latest transaction made, Ameritas Advisory Services, LLC holds 10,438 shares of NVS stock, worth $1.09 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
10,438
Previous 11,400 8.44%
Holding current value
$1.09 Million
Previous $1.21 Million 1.07%
% of portfolio
0.05%
Previous 0.05%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

SELL
$106.13 - $120.89 $102,097 - $116,296
-962 Reduced 8.44%
10,438 $1.2 Million
Q2 2024

Jul 29, 2024

SELL
$92.57 - $107.37 $12,034 - $13,958
-130 Reduced 1.13%
11,400 $1.21 Million
Q1 2024

May 14, 2024

BUY
$95.27 - $108.47 $10,574 - $12,040
111 Added 0.97%
11,530 $1.12 Million
Q4 2023

Feb 14, 2024

SELL
$92.27 - $101.54 $128,624 - $141,546
-1,394 Reduced 10.88%
11,419 $1.15 Million
Q3 2023

Nov 13, 2023

BUY
$94.73 - $105.13 $874,073 - $970,034
9,227 Added 257.31%
12,813 $1.31 Million
Q2 2023

Jul 25, 2023

SELL
$92.52 - $104.91 $640,330 - $726,082
-6,921 Reduced 65.87%
3,586 $361,000
Q1 2023

Apr 28, 2023

BUY
$80.03 - $92.81 $17,206 - $19,954
215 Added 2.09%
10,507 $966,000
Q4 2022

Feb 10, 2023

BUY
$75.55 - $92.52 $450,882 - $552,159
5,968 Added 138.02%
10,292 $933,000
Q3 2022

Nov 14, 2022

BUY
$74.61 - $87.26 $5,148 - $6,020
69 Added 1.62%
4,324 $329,000
Q2 2022

Aug 10, 2022

SELL
$80.52 - $93.75 $32,208 - $37,500
-400 Reduced 8.59%
4,255 $360,000
Q1 2022

May 04, 2022

SELL
$80.11 - $90.62 $13,057 - $14,771
-163 Reduced 3.38%
4,655 $408,000
Q4 2021

Feb 07, 2022

BUY
$79.7 - $88.13 $383,994 - $424,610
4,818 New
4,818 $421,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $224B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Ameritas Advisory Services, LLC Portfolio

Follow Ameritas Advisory Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameritas Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ameritas Advisory Services, LLC with notifications on news.